VanEck Associates
MD icon

VanEck Associates’s Pediatrix Medical MD Stock Holding History

VanEck Associates’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-610
Closed -$39K – 880
2016
Q1 		$39K Buy
610
+100
+20% +$6.63K ﹤0.01% 736
2015
Q4 		$37K Buy
+510
New +$37.7K ﹤0.01% 693

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VanEck Associates's MD Position: Q2 2016 in Review

VanEck Associates sold out of Pediatrix Medical (MD) in Q2 2016, closing a stake of 610 shares — an estimated $39K sold.

VanEck Associates first reported a position in MD in Q4 2015 and held it in 2 quarters. The position peaked at $39K in Q1 2016. 391 funds tracked by Wall St. Rank hold MD as of Q2 2016.

  • VanEck Associates reported no remaining Pediatrix Medical position as of Q2 2016 after selling out during the quarter.
  • VanEck Associates sold 610 Pediatrix Medical shares in Q2 2016, an estimated $39K.
  • VanEck Associates first reported a position in Pediatrix Medical in Q4 2015 and held it in 2 quarters.
  • VanEck Associates's Pediatrix Medical position peaked at $39K in Q1 2016.
  • 391 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2016.

Based on VanEck Associates's 13F filing for Q2 2016, filed 12 Aug 2016.